Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Recently T-helper 17 (Th17) cells were demonstrated to disrupt the blood-brain barrier (BBB) by the action of IL-17A. The aim of the present study was to examine the mechanisms that underlie IL-17A-induced BBB breakdown. Barrier integrity was analyzed in the murine brain endothelial cell line bEnd.3 by measuring the electrical resistance values using electrical call impedance sensing technology. Furthermore, in-cell Western blots, fluorescence imaging, and monocyte adhesion and transendothelial migration assays were performed. Experimental autoimmune encephalomyelitis (EAE) was induced in C57BL/6 mice. IL-17A induced NADPH oxidase- or xanthine oxidase-dependent reactive oxygen species (ROS) production. The resulting oxidative stress activated the endothelial contractile machinery, which was accompanied by a down-regulation of the tight junction molecule occludin. Blocking either ROS formation or myosin light chain phosphorylation or applying IL-17A-neutralizing antibodies prevented IL-17A-induced BBB disruption. Treatment of mice with EAE using ML-7, an inhibitor of the myosin light chain kinase, resulted in less BBB disruption at the spinal cord and less infiltration of lymphocytes via the BBB and subsequently reduced the clinical characteristics of EAE. These observations indicate that IL-17A accounts for a crucial step in the development of EAE by impairing the integrity of the BBB, involving augmented production of ROS.-Huppert, J., Closhen, D., Croxford, A., White, R., K…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [127]
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [65]
Citations
Cites
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · cited 4×
“Recently, it was shown that both IL-17A and IL-22 can disturb BBB integrity, but the exact mechanism by which this occurs is not clear (5).”
BackgroundInfluentialSelf-citationMultiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740 · cited 1×
“Multiple sclerosis (MS) is an autoimmune inflammatory disease of the CNS that is characterized by sclerotic lesions found throughout the brain white matter (1).”
BackgroundIL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
TH-17 cells in the circle of immunity and autoimmunity
Bettelli, E., Oukka, M., & Kuchroo, V. K. (2007) · Nature Immunology · doi:10.1038/ni0407-345 · Cited by 1,517 · cited 1×
“A correlative link between IL-17A expression and the development of EAE has been well documented, as Th17 cells are abundant in the CNS of mice before and during the peak of the disease ( 35 ).”
BackgroundTzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187 · cited 1×
“Th17 cells, which produce the cytokines IL-17A, IL-17F, and IL-22, were shown to infiltrate the CNS in patients with MS and in mice with EAE (23, 24).”
BackgroundAn essential role for free radicals and derived species in signal transduction
Lander, H. M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.2.9039953 · Cited by 902 · cited 1×
“We and others have demonstrated previously that ROS-induced activation of the endothelial contractile machinery leads to BBB disruption (14, 16, 26, 27, 36).”
BackgroundGarcia, J. G. N., Liu, F., Verin, A. D., Birukova, A., Dechert, M. A., Gerthoffer, W. T., Bamberg, J. R., & English, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12450 · Cited by 886 · cited 1×
“The endothelial contractile machinery is strongly regulated by the phosphorylation of myosin light chains (MLCs) ( 28 ).”
BackgroundRouvier, E., Luciani, M. F., Mattéi, M. G., Denizot, F., & Golstein, P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5445 · Cited by 775
Research works printed but not linked: 1
- 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q · DOI
Cited by
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
“This prevents the local generation of terminally differentiated effector T cells and T EM cells in the CNS, and it abrogates T cell-mediated astrogliosis and disruption of the blood–brain barrier (BBB”
BackgroundMultiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Functional morphology of the blood–brain barrier in health and disease
Liebner, S., Dijkhuizen, R. M., Reiss, Y., Plate, K. H., Agalliu, D., & Constantin, G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1815-1 · Cited by 872
Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms
Huang, X., Hussain, B., & Chang, J. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13569 · Cited by 709
Cytokine networks in neuroinflammation
Becher, B., Spath, S., & Goverman, J. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.123 · Cited by 697
Self-citationThe Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders
Knezevic, E., Nenic, K., Milanovic, V., & Knezevic, N. N. (2023) · Cells · doi:10.3390/cells12232726 · Cited by 564
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
BackgroundGlial influence on the blood brain barrier
Alvarez, J. I., Katayama, T., & Prat, A. (2013) · Glia · doi:10.1002/glia.22575 · Cited by 544
“These cytokines have been implicated in the modulation of EC function by upregulating the expression of proinflammatory mediators and by affecting the expression of junctional proteins and thus compromising BBB permeability (Alvarez et al., 2011a; Huppert et al., 2010; Kebir et al., 2007) (Fig.”
BackgroundMou, Y., Du, Y., Zhou, L., Yue, J., Hu, X., Liu, Y., Chen, S., Lin, X., Zhang, G., Xiao, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.796288 · Cited by 432
“3 cells, IL-17A amplified the endothelial production of reactive oxygen species (ROS) followed by cellular contractile mechanism activation and CLDN downregulation (75).”
BackgroundMechanisms of Blood–Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids
Fock, E., & Parnova, R. (2023) · Cells · doi:10.3390/cells12040657 · Cited by 385
How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Larochelle, C., Alvarez, J. I., & Prat, A. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.066 · Cited by 405
“IL17 appears to promote lymphocyte and monocyte migration also by increasing CCL2, IL-6 and CXCL8 secretion by BBB-ECs [89], and through an increase in ROS formation in ECs that could affect their contractile machinery via phosphorylation of the myosin light chain [94].”
BackgroundImmune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?
Qiu, Y.-M., Zhang, C.-L., Chen, A.-Q., Wang, H.-L., Zhou, Y.-F., Li, Y.-N., & Hu, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678744 · Cited by 399
“IL-17 also reduced the expression of TJs in ECs by increasing ROS production in an NADPH oxidase- or xanthine oxidasedependent manner (117).”
BackgroundTh17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
Jadidi‐Niaragh, F., & Mirshafiey, A. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02536.x · Cited by 384
Essentials of Th17 cell commitment and plasticity
Muranski, P., & Restifo, N. P. (2013) · Blood · doi:10.1182/blood-2012-09-378653 · Cited by 383
“In EAE, IL-17 induces reactive oxygen species production in the endothelium, leading to a disruption of the blood–brain barrier.(100) IL-17 promotes inflammatory cytokines (IL-1 and IL-6) and CCL20 (MIP3a), a potent chemotactic factor for myeloid cells, and additional Th17 cells expressing high levels of its receptor…”
BackgroundInterleukin-17 and innate immunity in infections and chronic inflammation
Isailovic, N., Daigo, K., Mantovani, A., & Selmi, C. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.04.006 · Cited by 363
Varrin‐Doyer, M., Spencer, C. M., Schulze‐Topphoff, U., Nelson, P. A., Stroud, R. M., C. Cree, B. A., & Zamvil, S. S. (2012) · Annals of Neurology · doi:10.1002/ana.23651 · Cited by 341
The role of IL-17 in CNS diseases
Waisman, A., Hauptmann, J., & Regen, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1402-7 · Cited by 340
“In addition, IL-17 has been shown to support monocyte migration across the BBB via an intracellular adhesion molecule (ICAM) 1-dependent mechanism [32].”
BackgroundSelf-citationDisruption of central nervous system barriers in multiple sclerosis
Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334
“Reactive oxygen species, in particular H2O2, has been shown to promote BBB disruption [63,88,115,169] and to favor immune cell attachment to BBB-EC [172].”
BackgroundResultHeckman, K. L., DeCoteau, W., Estevez, A., Reed, K. J., Costanzo, W., Sanford, D., Leiter, J. C., Clauss, J., Knapp, K., Gomez, C., et al. (2013) · ACS Nano · doi:10.1021/nn403743b · Cited by 320
Rajeev, V., Fann, D. Y., Dinh, Q. N., Kim, H. A., De Silva, T. M., Lai, M. K. P., Chen, C. L.-H., Drummond, G. R., Sobey, C. G., & Arumugam, T. V. (2022) · Theranostics · doi:10.7150/thno.68304 · Cited by 296
“IL-17 primarily exerts neuroinflammatory properties, but also promotes oxidative stress by inducing NADPH oxidase [170].”
BackgroundRedox Control of Microglial Function: Molecular Mechanisms and Functional Significance
Rojo, A. I., McBean, G., Cindric, M., Egea, J., López, M. G., Rada, P., Zarkovic, N., & Cuadrado, A. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5745 · Cited by 309
“Accordingly, IL-17-induced NOX-or xanthine oxidase-dependent ROS production activates the BBB-endothelial contractile machinery, which is accompanied by a down-regulation of occludin (109).”
Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension
Nguyen, H., Chiasson, V. L., Chatterjee, P., Kopriva, S. E., Young, K. J., & Mitchell, B. M. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvs422 · Cited by 300
“In addition to the decreased NO production caused by altered eNOS phosphorylation, decreased NO bioavailability due to RhoA/ Rho-kinase-mediated increases in superoxide production probably also contributes to the hypertension and endothelial dysfunction as superoxide quenching was able to restore endothelial function…”
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 282
Li, F., Wang, Y., Yu, L., Cao, S., Wang, K., Yuan, J., Wang, C., Wang, K., Cui, M., & Fu, Z. F. (2015) · Journal of Virology · doi:10.1128/jvi.00143-15 · Cited by 278
“Brain microvascular endothelial cells (BMECs) comprise the major component of the BBB, and the tight junctions (TJ) between BMECs determine and limit the paracellular permeability.”
BackgroundInfluentialVitiligo: interplay between oxidative stress and immune system
Laddha, N. C., Dwivedi, M., Mansuri, M. S., Gani, A. R., Ansarullah, M., Ramachandran, A. V., Dalai, S., & Begum, R. (2013) · Experimental Dermatology · doi:10.1111/exd.12103 · Cited by 273
Inflammatory mediators in human epilepsy: A systematic review and meta-analysis
de Vries, E. E., van den Munckhof, B., Braun, K. P. J., van Royen-Kerkhof, A., de Jager, W., & Jansen, F. E. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.007 · Cited by 269
The impact of chronic blood–brain barrier breach on intracortical electrode function
Saxena, T., Karumbaiah, L., Gaupp, E. A., Patkar, R., Patil, K., Betancur, M., Stanley, G. B., & Bellamkonda, R. V. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.007 · Cited by 266
“IL17a also disrupts the BBB and increases BBB permeability by increasing oxidative stress [60].”
BackgroundInterleukin-17 in chronic inflammatory neurological diseases
Milovanovic, J., Arsenijevic, A., Stojanovic, B., Kanjevac, T., Arsenijevic, D., Radosavljevic, G., Milovanovic, M., & Arsenijevic, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00947 · Cited by 250
“Although ischemia-reperfusion induces necrosis of blood–brain barrier, IL-17 could enhance BBB damage by the disruption of tight junctions (120) and by the promotion of monocyte migration across the BBB through an intracellular adhesion molecule (ICAM) 1-dependent mechanism (159).”
BackgroundCruz-Orengo, L., Holman, D. W., Dorsey, D., Zhou, L., Zhang, P., Wright, M., McCandless, E. E., Patel, J. R., Luker, G. D., Littman, D. R., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102010 · Cited by 231
Lehner, C., Gehwolf, R., Tempfer, H., Krizbai, I., Hennig, B., Bauer, H.-C., & Bauer, H. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3923 · Cited by 232
“Blocking either ROS formation or myosin light chain phosphorylation prevented IL-17A-induced BBB disruption (70).”
Gong, W., Guo, P., Li, Y., Liu, L., Yan, R., Liu, S., Wang, S., Xue, F., Zhou, X., & Yuan, Z. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.4974 · Cited by 225
Meng, J., Yu, H., Ma, J., Wang, J., Banerjee, S., Charboneau, R., Barke, R. A., & Roy, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054040 · Cited by 212
“Recent studies showed that myosin light chain kinase (MLCK) regulates the contraction of tight junctions by phosphorylating myosin light chains [24,33,34].”
InfluentialAnimal models of multiple sclerosis—Potentials and limitations
Mix, E., Meyer-Rienecker, H., Hartung, H.-P., & Zettl, U. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.005 · Cited by 210
“They seem to be important as antagonists of CD4+ Th17 cells (Afzali et al., 2007; Littman and Rudensky, 2010; Quintana et al., 2008a) that are supposed to be effector cells in EAE (Hofstetter et al., 2007; Huppert et al., 2010; Liu et al., 2010; Steinman, 2007) and MS (Gold and Lühder, 2008).”
BackgroundA basic overview of multiple sclerosis immunopathology
Grigoriadis, N., & van Pesch, V. (2015) · European Journal of Neurology · doi:10.1111/ene.12798 · Cited by 204
Rahman, M. T., Ghosh, C., Hossain, M., Linfield, D., Rezaee, F., Janigro, D., Marchi, N., & van Boxel-Dezaire, A. H. H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.021 · Cited by 189
Tight Junctions in Brain Barriers During Central Nervous System Inflammation
Coisne, C., & Engelhardt, B. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3929 · Cited by 186
“Recently, the mechanism underlying BBB alteration through IL-17A was associated with the production of ROS by NADPH oxidase and xanthine-oxidase in bEnd.3 cells (60).”
Mechanisms regulating regional localization of inflammation during CNS autoimmunity
Pierson, E., Simmons, S. B., Castelli, L., & Goverman, J. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01126.x · Cited by 175
“Human endothelial cells express IL-17 receptor, and IL-17 disrupts tight junctions in the blood brain barrier to facilitate migration of CD4+ T cells across the blood brain barrier in humans and mice (42, 79).”
BackgroundChai, Q., He, W. Q., Zhou, M., Lu, H., & Fu, Z. F. (2014) · Journal of Virology · doi:10.1128/jvi.03149-13 · Cited by 174
“Alteration of TJ protein expression has been observed in viral infections (MAV-1) or autoimmune diseases (EAE) (26, 28).”
BackgroundInfluentialNon-muscle myosin II in disease: mechanisms and therapeutic opportunities
Newell-Litwa, K. A., Horwitz, R., & Lamers, M. L. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.022103 · Cited by 169
Ni, P., Dong, H., Wang, Y., Zhou, Q., Xu, M., Qian, Y., & Sun, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1374-3 · Cited by 161
“In an experimental autoimmune encephalomyelitis (EAE) model, IL-17A induced BBB breakdown by reactive oxygen species (ROS) production and a decrease in tight junctions (TJs) [24].”
Cho, K., Suh, J. W., Lee, K. H., Kang, J. L., & Woo, S. (2011) · International Immunology · doi:10.1093/intimm/dxr110 · Cited by 161
Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
Podbielska, M., Banik, N., Kurowska, E., & Hogan, E. (2013) · Brain Sciences · doi:10.3390/brainsci3031282 · Cited by 146
“Upon breaching the BBB, the autoreactive CD4+ T cells initiate the local pro-inflammatory cascade.”
BackgroundInfluentialdos Passos, G. R., Sato, D. K., Becker, J., & Fujihara, K. (2016) · Mediators of Inflammation · doi:10.1155/2016/5314541 · Cited by 171
“Different compounds from the environment, including commensal microbiota and human pathogens, can act as a ligand for the AHR;moreover, such compoundsmay act only locally (i.e., in the mucosal tissues) or reach the circulation, causing changes in the immune system of different compartments [7].”
BackgroundThe role of IL-17 in vitiligo: A review
Singh, R. K., Lee, K. M., Vujkovic-Cvijin, I., Ucmak, D., Farahnik, B., Abrouk, M., Nakamura, M., Zhu, T. H., Bhutani, T., Wei, M., et al. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.01.004 · Cited by 145
“In addition, neutrophil influx promotes production of several ROS[80].”
BackgroundInfluentialBlood-Brain Barrier Disruption Induced by Chronic Sleep Loss: Low-Grade Inflammation May Be the Link
Hurtado-Alvarado, G., Domínguez-Salazar, E., Pavon, L., Velázquez-Moctezuma, J., & Gómez-González, B. (2016) · Journal of Immunology Research · doi:10.1155/2016/4576012 · Cited by 137
“Blood-Brain Barrier Modulation”
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 156
Hu, S., Wu, Y., Zhao, B., Hu, H., Zhu, B., Sun, Z., Li, P., & Du, S. (2018) · Molecules · doi:10.3390/molecules23112781 · Cited by 141
“Accumulating evidence indicates that oxidative stress injures endothelial cells, degrades TJs and contributes to an increase in BBB permeability [26,39,40].”
BackgroundBreaking the Barrier: The Role of Proinflammatory Cytokines in BBB Dysfunction
Gryka-Marton, M., Grabowska, A. D., & Szukiewicz, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083532 · Cited by 153
“Studies have shown that IL-17 induces the production of reactive oxygen species (ROS) via NADPH oxidase and xanthine oxidase pathways, leading to oxidative stress that activates the endothelial contractile machinery, ultimately increasing BBB permeability [112].”
Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities
Miljković, D., & Spasojević, I. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5068 · Cited by 134
“Reboldi et al . also found CCR6 + T cells in early cortical lesions, which implies that T cells infiltrate CSF using choroid plexus/CCL20 route (377) and may proceed to the cortex by provoking IL-17-dependent redistribution of CCL20 on the walls of blood vessels (103).”
InfluentialLuchtman, D. W., Ellwardt, E., Larochelle, C., & Zipp, F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.013 · Cited by 144
“expression and of endothelial cell (EC) contractility [83,94,95].”
BackgroundTh17 and Cognitive Impairment: Possible Mechanisms of Action
Cipollini, V., Anrather, J., Orzi, F., & Iadecola, C. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00095 · Cited by 146
“, 2018) and murine brain endothelial cell line (Huppert et al., 2010), IL-17 was shown to disrupt barrier integrity.”
BackgroundRigor, R. R., Shen, Q., Pivetti, C. D., Wu, M. H., & Yuan, S. Y. (2013) · Medicinal Research Reviews · doi:10.1002/med.21270 · Cited by 130
Th17 Pathway-Mediated Immunopathogenesis of Schizophrenia: Mechanisms and Implications
Debnath, M., & Berk, M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu049 · Cited by 129
Shekhar, S., Cunningham, M., Pabbidi, M. R., Wang, S., Booz, G. W., & Fan, F. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.028 · Cited by 137
“Furthermore, B cell-deficient mice were not protected against stroke, supporting the notion that T cells are critical for CNS injury after ischemic stroke (Hurn et al., 2007).”
InfluentialDileepan, T., Smith, E. D., Knowland, D., Hsu, M., Platt, M., Bittner-Eddy, P., Cohen, B., Southern, P., Latimer, E., Harley, E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80792 · Cited by 128
“IL-17A can disrupt BBB function in vitro and in vivo through the generation of ROS in endothelial cells (19, 20).”
BackgroundWong, H., & Hoeffer, C. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.010 · Cited by 129
“However, IL-17A stimulation of endothelial IL-17RA have been shown to promote BBB permeability by causing the disruption of tight junctions and release of signals that recruit macrophages to the area (Huppert et al., 2010; Kebir et al., 2007).”
BackgroundCytokines and effector T cell subsets causing autoimmune CNS disease
Petermann, F., & Korn, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.064 · Cited by 128
“Moreover IL-17R engagement increases the generation of reactive oxygen species (ROS) in brain endothelial cells resulting in disorganization of tight junctions and subsequently in blood brain barrier impairment [78,79].”
BackgroundMa, Y., Yang, S., He, Q., Zhang, D., & Chang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.784098 · Cited by 133
“Several studies have revealed that IL-17A compromises BBB integrity by reducing the expression of tight junction proteins (TJs), including occludin and ZO-1, in ECs by inducing a robust elevation level of ROS in an NADPH oxidase-or xanthine oxidase-dependent manner (114, 115).”
Berry, S. P. D.-G., Dossou, C., Kashif, A., Sharifinejad, N., Azizi, G., Hamedifar, H., Sabzvari, A., & Zian, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108402 · Cited by 124
Pathogenic T cell cytokines in multiple sclerosis
Wagner, C. A., Roqué, P. J., & Goverman, J. M. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190460 · Cited by 122
Role of Th17 and IL-17 Cytokines on Inflammatory and Auto-immune Diseases
Akhter, S., Tasnim, F. M., Islam, M. N., Rauf, A., Mitra, S., Emran, T. B., Alhumaydhi, F. A., Khalil, A. A., Aljohani, A. S. M., Abdulmonem, W. A., et al. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230904150808 · Cited by 143
Golzari, Z., Shabkhiz, F., Soudi, S., Kordi, M. R., & Hashemi, S. M. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.008 · Cited by 145
“The role of IL17 in pathogenesis of experimental allergic encephalomyelitis (EAE) has been detected in some studies [9,28,29], and the recent study indicated that IL-17 participates in the development of EAE by impairing the integrity of the blood-brain barrier [30].”
BackgroundCurcumin has bright prospects for the treatment of multiple sclerosis
Xie, L., Li, X., & Takahara, S. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.013 · Cited by 118
Ronchi, F., Basso, C., Preite, S., Reboldi, A., Baumjohann, D., Perlini, L., Lanzavecchia, A., & Sallusto, F. (2016) · Nature Communications · doi:10.1038/ncomms11541 · Cited by 115
Therapeutic potential of curcumin for multiple sclerosis
Qureshi, M., Al-Suhaimi, E. A., Wahid, F., Shehzad, O., & Shehzad, A. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3149-5 · Cited by 124
Balasa, R., Barcutean, L., Balasa, A., Motataianu, A., Roman-Filip, C., & Manu, D. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.02.009 · Cited by 107
Meng, J., Banerjee, S., Li, D., Sindberg, G. M., Wang, F., Ma, J., & Roy, S. (2015) · Scientific Reports · doi:10.1038/srep10918 · Cited by 111
Factors Predisposing to Coma and Delirium
Skrobik, Y. K., Léger, C., Cossette, M., Michaud, V., & Turgeon, J. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e318275d014 · Cited by 116
“IL-17 contributes to BBB dysfunction (43) in mice; anti-inflammatory IL-1RA and IL-10 also appear to be associated with BBB dysfunction (44, 45).”
BackgroundPaintlia, M. K., Paintlia, A. S., Singh, A. K., & Singh, I. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07136.x · Cited by 108
“IL-17-induced ROS generation in endothelial cells have been implicated in the compromised blood brain barrier integrity in MS model (Huppert et al. 2009).”
BackgroundInitial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
Hernández-Pedro, N. Y., Espinosa-Ramirez, G., de la Cruz, V. P., Pineda, B., & Sotelo, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/413465 · Cited by 108
Regulation of paracellular permeability: factors and mechanisms
Hu, Y.-J., Wang, Y., Tan, F.-Q., & Yang, W. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2724-y · Cited by 129
The role of Th17 cells in auto-inflammatory neurological disorders
Tahmasebinia, F., & Pourgholaminejad, A. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.023 · Cited by 122
IL‐17 and Glutamate Excitotoxicity in the Pathogenesis of Multiple Sclerosis
Kostic, M., Dzopalic, T., Zivanovic, S., Zivkovic, N., Cvetanovic, A., Stojanovic, I., Vojinovic, S., Marjanovic, G., Savic, V., & Colic, M. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12147 · Cited by 102
Blood-brain barrier disruption: a culprit of cognitive decline?
Che, J., Sun, Y., Deng, Y., & Zhang, J. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00563-3 · Cited by 124
“Furthermore, IL-17 A secreted from Th17 cells can induce NADPH oxidase-or xanthine oxidase-dependent ROS production, and activate the endothelial contractile machinery, leading to occludin downregulation and BBB disruption [242].”
BackgroundRole of tumor necrosis factor superfamily in neuroinflammation and autoimmunity
Sonar, S. A., & Lal, G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00364 · Cited by 118
Sera from neuromyelitis optica patients disrupt the blood–brain barrier
Shimizu, F., Sano, Y., Takahashi, T., Haruki, H., Saito, K., Koga, M., & Kanda, T. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300434 · Cited by 101
Voirin, A.-C., Perek, N., & Roche, F. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146647 · Cited by 99
Jones, B. E., Tovar, K. R., Goehring, A. S., Jalali‐Yazdi, F., Okada, N. J., Gouaux, E., & Westbrook, G. L. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw0044 · Cited by 109
“For example, interleukin-17 (IL-17), a proinflammatory cytokine produced by T helper 17 CD4+ T cells, is prominent in the CSF of human cases and may perform the dual role of bloodbrain barrier disruption and up-regulation of IL-6, a pro–B cell and plasma cell cytokine (62, 66, 67).”
BackgroundThe role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A
Fu, J., Huang, Y., Bao, T., Liu, C., Liu, X., & Chen, X. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02446-6 · Cited by 107
Jun, L., Xu, W., Zhang, Z. W., Huang, H., Zhang, L. M., & Zhou, J. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00294.x · Cited by 100
“found that IL17A-induced blood-brain barrier disruption involves the formation of reactive oxygen species (ROS) by NAD(P)H oxidase and xanthine oxidase, which subsequently are responsible for the disruption and downregulation of tight junction molecules and the activation of the endothelial contractile machinery (Hupp…”
BackgroundReactive Oxygen Species in Pathogenesis of Atherosclerosis
Goncharov, N., Avdonin, P., Nadeev, A., Zharkikh, I., & Jenkins, R. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612820666141014142557 · Cited by 97
“ROS interacts with ionic channels, cytoskeletal and adhesive proteins, enhancing endothelial permeability due to activation of contractile proteins and degradation of occludin, the principal tight junction protein [63, 64].”
BackgroundIncreased production of IL-17 in children with autism spectrum disorders and co-morbid asthma
Akintunde, M. E., Rose, M., Krakowiak, P., Heuer, L., Ashwood, P., Hansen, R., Hertz-Picciotto, I., & Van de Water, J. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.07.003 · Cited by 96
Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain
Peng, Z., Peng, S., Lin, K., Zhao, B., Wei, L., Tuo, Q., Liao, D., Yuan, T., & Shi, Z. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02543-6 · Cited by 95
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
BackgroundHalwani, R., Sultana, A., Vazquez‐Tello, A., Jamhawi, A., Al‐Masri, A. A., & Al‐Muhsen, S. (2017) · Journal of Asthma · doi:10.1080/02770903.2017.1283696 · Cited by 97
Setiadi, A. F., Abbas, A. R., Jeet, S., Wong, K., Bischof, A., Peng, I., Lee, J., Bremer, M., Eggers, E. L., DeVoss, J., et al. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.04.011 · Cited by 93
T cell mediated pathogenesis in EAE: Molecular mechanisms
Kurschus, F. C. (2015) · Biomedical Journal · doi:10.4103/2319-4170.155590 · Cited by 103
“IL‐17 probably also acts directly on the blood–brain barrier (BBB) integrity by induction of reactive oxygen species (ROS) in endothelial cells.([68]) IL‐17 was also shown to induce down‐ stream mediators of angiogenesis in rheumatoid arthritis and tumor models and in psoriasis.”
BackgroundTh17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi
Cai, C. W., Blase, J. R., Zhang, X., Eickhoff, C. S., & Hoft, D. F. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005902 · Cited by 103
Proinflammatory CD20 + T cells contribute to CNS-directed autoimmunity
Ochs, J., Nissimov, N., Torke, S., Freier, M., Grondey, K., Koch, J., Klein, M., Feldmann, L., Gudd, C. L. C., Bopp, T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abi4632 · Cited by 91
Th17 cells in central nervous system autoimmunity
Sie, C., Korn, T., & Mitsdoerffer, M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.03.009 · Cited by 101
Chai, Q., She, R., Huang, Y., & Fu, Z. F. (2014) · Journal of Virology · doi:10.1128/jvi.02154-14 · Cited by 101
“IL-17 has been reported to be a crucial determinant for tight junction (TJ) protein alteration and BBB disruption (27).”
BackgroundWanke, F., Moos, S., Croxford, A. L., Heinen, A. P., Gräf, S., Kalt, B., Tischner, D., Zhang, J., Christen, I., Bruttger, J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.020 · Cited by 97
Self-citationDEL-1-Regulated Immune Plasticity and Inflammatory Disorders
Hajishengallis, G., & Chavakis, T. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.02.010 · Cited by 93
“IL-17 can promote disruption of the blood-brain-barrier and increase endothelial permeability [55,56]; hence the upregulation of IL-17 in DEL-1 deficiency provides a potential mechanism for the disrupted barrier in DEL-1-deficient mice.”
BackgroundSlyepchenko, A., Maes, M., Köhler, C. A., Anderson, G., Quevedo, J., Alves, G. S., Berk, M., Fernandes, B. S., & Carvalho, A. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.002 · Cited by 89
Liu, C., Zhu, J., Zheng, X., Ma, C., & Wang, X. (2017) · Mediators of Inflammation · doi:10.1155/2017/6361479 · Cited by 100
“Regardless of immunoglobulin class (IgM, IgA, and IgG), all circulating autoantibodies against the NR1 subunit of NMDA receptors may have pathogenic potential on access to the brain in the condition of increased BBB permeability [82].”
BackgroundPericytes: brain-immune interface modulators
Hurtado-Alvarado, G., Cabañas-Morales, A. M., & Gómez-Gónzalez, B. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00080 · Cited by 90
Wojkowska, D. W., Szpakowski, P., & Glabinski, A. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051000 · Cited by 93
“This deregulation increases the permeability of the BBB to leukocytes, which is considered to be the first step of MS development [11].”
BackgroundInfluentialByun, J., Lee, S., Moon, J., Jung, K., Sunwoo, J., Lim, J., Kim, T., Shin, Y., Lee, K., Jun, J., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.05.023 · Cited by 91
“IL-17 also down-regulates tight junction molecules and facilitates leukocyte trafficking across the blood-brain-barrier (BBB) (Huppert et al., 2010), likely initiating CNS inflammation andpromoting intrathecal antibody production.”
BackgroundJha, M., & Trivedi, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010233 · Cited by 86
“Peripheral IL-17 binds to the IL-17 receptors on the BBB leading to the generation of reactive oxygen species (ROS), which in turn increase BBB permeability [67].”
BackgroundBennett, C., Mohammed, F. S., Álvarez-Ciara, A., Nguyen, M. A., Dietrich, W. D., Rajguru, S. M., Streit, W. J., & Prasad, A. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.040 · Cited by 90
Vaccination in Multiple Sclerosis: Friend or Foe?
Zrzavy, T., Kollaritsch, H., Rommer, P. S., Boxberger, N., Loebermann, M., Wimmer, I., Winkelmann, A., & Zettl, U. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01883 · Cited by 85
“IL-17 plays a major role in autoimmunity and MS and may trigger the migration of peripheral lymphocytes into the CNS across the BBB (20, 21).”
BackgroundInterleukin-17 in post-stroke neurodegeneration
Swardfager, W., Winer, D. A., Herrmann, N., Winer, S., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.021 · Cited by 94
Metadata
- Authors
- Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., & Kuhlmann, C. R. W.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- University of Zurich (CH)
- Leipzig University (DE)
- Corresponding author
- Waisman, Ari
- Kuhlmann, Christoph R. W.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-11-25
- Volume
- 24
- Issue
- 4
- Pages
- 1023-1034
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2071205488
- Semantic Scholar
- 28487cafa06774aea634538871f39aa337f374e1
- Cited by
- 529
- References
- 41
- Citations by year
- 2026: 29 · 2025: 41 · 2024: 43 · 2023: 40 · 2022: 43 · 2021: 44 · 2020: 21 · 2019: 21 · 2018: 31 · 2017: 28 · 2016: 32 · 2015: 31 · 2014: 27 · 2013: 35 · 2012: 15
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Deutsche Forschungsgemeinschaft (SFB TR52/C2)
- Boehringer Ingelheim Stiftung
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- IL-17A, blood-brain barrier disruption, Th17 cells, experimental autoimmune encephalomyelitis, reactive oxygen species, NADPH oxidase, xanthine oxidase, oxidative stress, myosin light chain phosphorylation, myosin light chain kinase, ML-7, occludin, tight junctions, endothelial contractility, monocyte adhesion, lymphocyte transendothelial migration, bEnd.3 endothelial cells
- MeSH terms
- Animals, Azepines, Blood-Brain Barrier, Cell Line, Transformed, Encephalomyelitis, Autoimmune, Experimental, Enzyme Inhibitors, T-Lymphocytes, Helper-Inducer, Membrane Proteins, Mice, Inbred BALB C, Myosin-Light-Chain Kinase, Naphthalenes, Xanthine Oxidase, Down-Regulation, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases, Interleukin-17, Endothelial Cells, Mice, Antibodies, Neutralizing, Occludin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.